Bicycle Therapeutics plc (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

3.630

-0.170 (-4.47%)

At close: Oct 13, 2026, 4:00 PM EDT

3.640

+0.010 (0.28%)

After-hours: Oct 13, 2026, 4:00 PM EDT

Bicycle Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	61.21	72.59	35.28	26.98	14.46	11.7
Revenue Growth	217.44%	105.77%	30.76%	86.52%	23.65%	12.58%
Cost of Revenue	189.06	229.08	164.86	147.65	81.61	44.88
Gross Profit	-127.85	-156.5	-129.59	-120.68	-67.15	-33.18
Selling, General & Admin	78.25	86.37	79.19	69.27	49.51	32.44
Operating Expenses	78.25	86.37	79.19	69.27	49.51	32.44
Operating Income	-206.1	-242.87	-208.77	-189.95	-116.65	-65.62
Interest Expense	-0.19	-0.21	-1.73	-3.26	-3.34	-2.98
Interest & Investment Income	21.81	28.46	34.28	14	5.76	0.12
EBT Excluding Unusual Items	-184.48	-214.61	-176.22	-179.21	-114.24	-68.48
Other Unusual Items	-4.2	-4.2	2.42	-	-	-
Pretax Income	-188.68	-218.81	-173.8	-179.21	-114.24	-68.48
Income Tax Expense	1.73	0.15	-4.77	1.46	-1.52	-1.66
Net Income	-190.41	-218.96	-169.03	-180.66	-112.72	-66.82
Net Income to Common	-190.41	-218.96	-169.03	-180.66	-112.72	-66.82
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	70	69	58	36	30	25
Shares Outstanding (Diluted)	70	69	58	36	30	25
Shares Change	0.52%	19.02%	63.54%	20.00%	18.35%	30.90%
EPS (Basic)	-2.74	-3.16	-2.90	-5.08	-3.80	-2.67
EPS (Diluted)	-2.74	-3.16	-2.90	-5.08	-3.80	-2.67
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-208.28	-252.03	-165.96	-63.56	-105.1	-16.82
Free Cash Flow Per Share	-3.00	-3.64	-2.85	-1.79	-3.54	-0.67
Gross Margin	-208.89%	-215.60%	-	-	-	-283.69%
Operating Margin	-336.74%	-334.59%	-591.84%	-704.13%	-806.56%	-560.98%
Profit Margin	-311.11%	-301.66%	-479.18%	-669.72%	-779.35%	-571.25%
Free Cash Flow Margin	-340.29%	-347.21%	-470.47%	-235.61%	-726.67%	-143.83%
EBITDA	-200.81	-236.44	-201.6	-183.4	-112.96	-64.21
D&A For EBITDA	5.29	6.42	7.17	6.55	3.69	1.41
EBIT	-206.1	-242.87	-208.77	-189.95	-116.65	-65.62

SEC Filings: 10-K · 10-Q